Abion Inc (203400)

15,950.00
-50.00(-0.31%)
  • Volume:
    135,844
  • Bid/Ask:
    15,900.00/15,950.00
  • Day's Range:
    15,750.00 - 16,600.00

203400 Overview

Prev. Close
16,000
Day's Range
15,750-16,600
Revenue
1.2B
Open
15,850
52 wk Range
5,070-26,200
EPS
-
Volume
135,844
Market Cap
284.59B
Dividend (Yield)
N/A
(N/A)
Average Vol. (3m)
207,515
P/E Ratio
-
Beta
1.19
1-Year Change
125.99%
Shares Outstanding
17,787,072
Next Earnings Date
-
What is your sentiment on Abion Inc?
or
Market is currently closed. Voting is open during market hours.

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellStrong SellStrong SellStrong SellBuy
Technical IndicatorsStrong SellStrong SellStrong SellStrong SellStrong Buy
SummaryStrong SellStrong SellStrong SellStrong SellStrong Buy

Abion Inc Company Profile

Abion Inc Company Profile

Employees
0

Abion Inc. engages in the development of chemical and biological drugs, and vaccines in South Korea and internationally. The company develops anticancer therapeutic drugs, such as ABN401, a drug candidate for lung and stomach cancer; ABN501, a biomarker for ovarian cancer; and ABN201, a fusion protein to target cancer cells. It also develops ABN101, an interferon-beta based biological drug for the treatment of autoimmune diseases in the central nervous system. In addition, the company is developing medical countermeasure vaccines, such as ABN701, a vaccine that protects against infection from staphylococcal enterotoxin B; and ABN601, a drug for the protection of immune system from acute radiation syndrome. Abion Inc. was founded in 2007 and is based in Seoul, South Korea.

Read More
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.